Elisabet Helsing
Elisabet Helsing is a Norwegian physician and nutritionist known for her work in the field of breastfeeding and infant nutrition. She has made significant contributions to the World Health Organization's (WHO) policies on infant feeding and has been instrumental in promoting breastfeeding globally.
Early Life and Education[edit]
Elisabet Helsing was born in Norway. She completed her medical studies in her home country before specializing in Public Health and Nutrition.
Career[edit]
Helsing began her career as a physician in Norway. She later moved into the field of public health and nutrition, focusing specifically on infant nutrition. She has worked with several international organizations, including the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF).
At the WHO, Helsing played a key role in developing the organization's policies on infant feeding. She was instrumental in the creation of the International Code of Marketing of Breast-milk Substitutes, a global health policy framework for advertising formula milk. This code has been adopted by many countries and has significantly reduced the inappropriate marketing of breast-milk substitutes.
Helsing has also been involved in numerous research projects related to breastfeeding and infant nutrition. Her work has contributed to a better understanding of the benefits of breastfeeding and the risks associated with formula feeding.
Recognition[edit]
In recognition of her contributions to the field of infant nutrition, Helsing has received several awards and honors. These include the Norwegian Medical Association's Public Health Prize and the Royal Norwegian Order of St. Olav.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
